ZYNERBA PHARMACEUTICALS INC's ticker is ZYNE and the CUSIP is 98986X109. A total of 68 filers reported holding ZYNERBA PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.66 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $258 | – | 46 | – | 0.00% | – |
Q2 2021 | $0 | – | 0 | – | 0.00% | – |
Q1 2021 | $0 | -100.0% | 0 | -100.0% | 0.00% | – |
Q1 2019 | $3,000 | +200.0% | 500 | +13.6% | 0.00% | – |
Q4 2018 | $1,000 | -75.0% | 440 | 0.0% | 0.00% | – |
Q3 2018 | $4,000 | 0.0% | 440 | 0.0% | 0.00% | – |
Q2 2018 | $4,000 | -42.9% | 440 | -25.4% | 0.00% | – |
Q1 2018 | $7,000 | 0.0% | 590 | 0.0% | 0.00% | – |
Q4 2017 | $7,000 | +16.7% | 590 | -14.5% | 0.00% | – |
Q3 2017 | $6,000 | -68.4% | 690 | -37.6% | 0.00% | -100.0% |
Q2 2017 | $19,000 | +72.7% | 1,105 | +104.6% | 0.00% | – |
Q1 2017 | $11,000 | -82.0% | 540 | -86.2% | 0.00% | -100.0% |
Q4 2016 | $61,000 | +144.0% | 3,900 | +105.3% | 0.00% | +200.0% |
Q3 2016 | $25,000 | +525.0% | 1,900 | +216.7% | 0.00% | – |
Q2 2016 | $4,000 | +33.3% | 600 | +20.0% | 0.00% | – |
Q1 2016 | $3,000 | – | 500 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Prentice Capital Management, LP | 390,381 | $1,292,000 | 0.49% |
ETF MANAGERS GROUP, LLC | 891,025 | $2,949,000 | 0.09% |
AdvisorShares Investments LLC | 353,009 | $1,168,000 | 0.06% |
ALGERT GLOBAL LLC | 51,028 | $169,000 | 0.05% |
Bernardo Wealth Planning LLC | 27,219 | $90,000 | 0.04% |
IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 31,552 | $104,000 | 0.03% |
ZEKE CAPITAL ADVISORS, LLC | 49,700 | $165,000 | 0.02% |
Walleye Capital LLC | 51,554 | $171,000 | 0.02% |
Dynamic Technology Lab Private Ltd | 19,021 | $63,000 | 0.01% |
J.W. COLE ADVISORS, INC. | 37,064 | $123,000 | 0.01% |